• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. PROTECTOR P50 MULTIPACK; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. PROTECTOR P50 MULTIPACK; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM Back to Search Results
Catalog Number 515106
Medical Device Problem Code Contamination (1120)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/25/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Initial mdr, if a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
Event details: this is a complaint about p50j protector coring during use.It was reported that endoxan and rituxan prepared.Assembly fixture used.Coaling fragments were observed in the vial.Rituxan collection vial was removed from p50 vial as the drug was collected.The coring fragments were collected while keeping a close eye on the vial, but the fragments moved and were difficult to find.2 rituxan vials are present.Note that a coma filter and capped needle are also enclosed.Lot number of the injector is 2501006.
 
Event or Problem Description
No additional information.
 
Additional Manufacturer Narrative
(b)(4).Follow up mdr for device evaluation: it was reported that particles were observed inside the vial.No injector samples were returned.Three protectors, each connected to a vial, were provided to our quality team for investigation.During visual inspection, particles were observed within each vial.Characterization testing was performed and found the particles are consistent with material from the stopper of the vial.An additional particle within one of the vials was identified to be silicone, which would have originated from the syringe.It was also noted that the stoppers were significantly torn in the areas where the needle penetrated.No issues were found within the protector needle itself that could have contributed to this observation.A device history review was performed for injector lot 2501006.No deviations or nonconformances were identified during the manufacturing process that could have contributed to this observation.As the protector lot involved in this incident is unknown, a device history review cannot be performed.While phaseal needles are designed to reduce coring, there are several factors that may impact coring tendency.Coring of the rubber stopper may result depending on the stopper quality, the design and dimensions of the needles used, or if a poor connection of the protector occurs.It is important to ensure the vial is not expired, as that can impact the quality of the rubber stopper.Based on our investigation and sample evaluation, it was determined that the stopper particles were generated during the assembly of the protector onto the vial.Complaints received for this device and reported condition will continue to be tracked and trended for future occurrence.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTECTOR P50 MULTIPACK
Common Device Name
CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer (Section G)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key23322179
Report Number3003152976-2025-00568
Device Sequence Number15937072
Product Code ONB
UDI-Device Identifier00382905151064
UDI-Public(01)00382905151064
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K123213
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/26/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number515106
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/25/2025
Supplement Date Received by Manufacturer04/28/2026
Initial Report FDA Received Date10/17/2025
Supplement Report FDA Received Date04/28/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-